ADVANCED METASTATIC BREAST CANCER
Clinical trials for ADVANCED METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injectable letrozole could offer same cancer control as pill
Disease control Not yet recruitingThis study tests if an injectable form of letrozole (Letrozole SIE) works as well as the standard pill (Femara) for controlling advanced breast cancer. Both groups also receive a targeted drug called ribociclib. About 300 postmenopausal women with HR-positive, HER2-negative breas…
Matched conditions: ADVANCED METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New hope for tired cancer patients: drug may stop fatigue before it starts
Symptom relief Not yet recruitingThis study tests if megestrol acetate, taken at the start of T-DXd treatment, can prevent or reduce fatigue in women with advanced breast cancer. About 132 women aged 18-75 with HER2-positive, low, or ultralow breast cancer will participate. The goal is to improve quality of life…
Matched conditions: ADVANCED METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated May 17, 2026 07:06 UTC